Intraoperative Lung-Protective Ventilation in Neurosurgery

August 28, 2023 updated by: Wei Zhang, Capital Medical University
The purpose of this study is to explore the effectiveness of lung-protective ventilation during general anesthesia for neurosurgical procedures on postoperative pulmonary outcome, compared with traditional ventilation.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

After screened for preoperative risk classification of postoperative respiratory complications,360 patients undergoing elective neurosurgery are randomly assigned to two groups, lung-protective ventilation (L) and traditional ventilation(T).Patients are mechanical ventilated with either a tidal volume of 10-12 ml/kg ideal body weight (IBW,T) or 6-8ml/kg IBW with 6-8 cm H2O PEEP(L),both with recruitment maneuver (RM).Each RM consists of applying a continuous positive airway pressure of 30 cmH2O for 30 seconds. Postoperative pulmonary complications are compared between groups.

Study Type

Interventional

Enrollment (Actual)

360

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100050
        • Department of Anesthesiology,Beijing Tiantan Hospital, Capital Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. > 40 years ,and < 80 years
  2. Scheduled for neurosurgery
  3. After informed consent has been obtained
  4. With an expected duration of ≥ 4 hours
  5. preoperative risk index for pulmonary complications≥ 2
  6. Glasgow Coma Scale >8

Exclusion Criteria:

  1. Mechanical ventilation of > 1 hour within the last 2 weeks before surgery
  2. Body mass index ≥ 35 kg/m2
  3. Acute respiratory failure (pneumonia, acute lung injury or acute respiratory distress syndrome)
  4. Emergency surgery
  5. Severe cardiac disease
  6. Progressive neuromuscular illness
  7. Pregnancy
  8. Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group L
lung-protective ventilation applied in anesthesia
mechanical ventilated with a tidal volume of 6-8ml/kg ideal body weight (IBW) and 6-8 cm H2O PEEP in anesthesia
No Intervention: Group T
traditional ventilation applied in anesthesia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pulmonary complications
Time Frame: 7 days after surgery
modified Clinical Pulmonary Infection Score (mCPIS):Temperature,Blood leukocytes,Tracheal secretions,Oxygenation Pao2/Fio2,Chest radiograph; Grade scale for postoperative pulmonary complications:Grade 0 representing the absence of any pulmonary complication and grades 1 through 4 representing successively the worse forms of complications
7 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative brain relaxation.
Time Frame: 1 day undergonging surgery
using a four-point scale: 1, completely relaxed; 2, satisfactorily relaxed; 3, firm brain; 4, bulging brain;
1 day undergonging surgery
The postoperative complications within 30 days
Time Frame: 30 days after surgery
Surgical complications,Systematic complications; Septic shock, Death
30 days after surgery
Postoperative hypoxemia
Time Frame: 7 days after surgery
PaO2 less than 60 mmHg, SpO2 less than 90%; PaO2 /FiO2 less than 300.
7 days after surgery
Peripheral blood inflammatory response indicators
Time Frame: 1 day after surgery
interleukin 6, tumor necrosis factor TNF-α.
1 day after surgery
Postoperative antibiotic usage
Time Frame: 30 days after surgery
antibiotic dose
30 days after surgery
Postoperative pulmonary complications
Time Frame: 30 days after surgery
modified Clinical Pulmonary Infection Score (mCPIS):Temperature,Blood leukocytes,Tracheal secretions,Oxygenation Pao2/Fio2,Chest radiograph; Grade scale for postoperative pulmonary complications:Grade 0 representing the absence of any pulmonary complication and grades 1 through 4 representing successively the worse forms of complications
30 days after surgery
Unanticipated ICU treatment.
Time Frame: 30 days after surgery
Unanticipated ICU treatment.
30 days after surgery
ICU stay and length of hospital stay
Time Frame: 30 days after surgery
ICU stay and length of hospital stay
30 days after surgery
All cause of mortality at 30 days
Time Frame: 30 days after surgery
mortality
30 days after surgery
Cost analysis
Time Frame: 30 days after surgery
Data of total non-operative costs, costs per day.
30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Ruquan Han, MD, Department of Anesthesiology, Beijing TianTan Hospital, Capital Medical University
  • Study Director: liyong Zhang, MD, Department of Anesthesiology, Beijing TianTan Hospital, Capital Medical University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2015

Primary Completion (Actual)

March 1, 2020

Study Completion (Actual)

November 1, 2020

Study Registration Dates

First Submitted

October 18, 2014

First Submitted That Met QC Criteria

March 6, 2015

First Posted (Estimated)

March 12, 2015

Study Record Updates

Last Update Posted (Actual)

August 30, 2023

Last Update Submitted That Met QC Criteria

August 28, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ventilator-induced Lung Injury

Clinical Trials on lung-protective ventilation

3
Subscribe